GLP1RAs Tied to Greater Risk of Diabetic Retinopathy Progression Than SGLT2is
No difference in ocular outcomes seen between the drugs among those without baseline diabetic retinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.